Vimab Group AB (OSTO:VIMAB) Other Current Receivables: kr63.3 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:VIMAB Vimab Group AB OSTO:VIMAB
52 GF Score
Price kr3.30
GF Value kr5.98
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Vimab Group AB Other Current Receivables?

Vimab Group AB OSTO:VIMAB +11.49% 52 Other Current Receivables is kr63.3 Mil as of Mar. 2026. GuruFocus rates OSTO:VIMAB with a GF Score™ of 52/100 and a GF Value™ of kr5.98 (Possible Value Trap). The stock has 5 warning signs investors should review.

Vimab Group AB's Other Current Receivables for the quarter that ended in Mar. 2026 was kr63.3 Mil.

Vimab Group AB's quarterly Other Current Receivables increased from Sep. 2025 (kr27.40 Mil) to Dec. 2025 (kr27.56 Mil) and increased from Dec. 2025 (kr27.56 Mil) to Mar. 2026 (kr63.30 Mil).

Vimab Group AB's annual Other Current Receivables declined from Dec. 2023 (kr37.50 Mil) to Dec. 2024 (kr20.45 Mil) but then increased from Dec. 2024 (kr20.45 Mil) to Dec. 2025 (kr27.56 Mil).

Vimab Group AB Other Current Receivables Related Terms

Vimab Group AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Vimab Group AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimab Group AB Other Current Receivables Chart

Vimab Group AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.62 8.91 37.50 20.45 27.56

Vimab Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.97 27.61 27.40 27.56 63.30
OSTO:VIMAB
52GF Score
Vimab Group AB OSTO:VIMAB
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vimab Group AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of kr63.3 Mil mean?
Vimab Group AB (OSTO:VIMAB) has a Other Current Receivables of kr63.3 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Vimab Group AB and its competitors.
Is Vimab Group AB's Other Current Receivables too high?
Vimab Group AB's current Other Current Receivables is kr63.3 Mil. Overall, Vimab Group AB has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's Other Current Receivables compare to VRSK and EFX?
Vimab Group AB's Other Current Receivables of kr63.3 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Business Services company?
A good Other Current Receivables depends on the Business Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Vimab Group AB and its competitors. Vimab Group AB's current Other Current Receivables is kr63.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Based on GuruFocus' analysis, Vimab Group AB (OSTO:VIMAB) is currently considered Possible Value Trap. The stock's GF Value™ is kr5.98, compared to a current price of kr3.30 — trading 44.8% below its estimated fair value. The current Other Current Receivables is kr63.3 Mil. Vimab Group AB's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Vimab Group AB (OSTO:VIMAB), the current Other Current Receivables is kr63.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimab Group AB (OSTO:VIMAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued. The current stock price of kr3.30 is trading 44.8% below its estimated GF Value™ of kr5.98. GuruFocus considers Vimab Group AB to be Possible Value Trap.

Key valuation signals for OSTO:VIMAB:

  • Other Current Receivables: kr63.3 Mil
  • GF Value™: kr5.98 vs. price of kr3.30 (44.8% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the OSTO:VIMAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vimab Group AB Business Description

Address Malmskillnadsgatan 40A, Stockholm, SWE, 111 57
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
52GF Score

Get the complete analysis for OSTO:VIMAB

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.30
Price
kr5.98
GF Value